Abstract
Anticancer metallodrug development has for a long time been characterised by the similarity of new drug candidates to cisplatin and DNA as the primary target. Recent advances in bioanalytical techniques with high sensitivity and selectivity have revealed that metal-based drugs can undergo a wide range of biomolecular interactions beyond DNA and have generated interest in proteins as possible targets for metallodrugs. In fact, implementation of metallomics approaches that are able to reveal the fate of the compounds in biological systems can help to move drug development towards more targeted and rational design of novel metallodrugs. Additionally, proteomic screening and gene expression analysis can provide insight into physiological response to drug treatment and identify the reasons for drug resistance. Herein, we review selected applications which led to a better understanding of the mode of action of clinically established metal-based anticancer agents and novel metallodrug candidates.
Similar content being viewed by others
References
Shaw CF (1999) Chem Rev 99:2589–2600
Kelland L (2007) Nat Rev Cancer 7:573–584
Ott I, Gust R (2007) Arch Pharm 340:117–126
Jakupec MA, Galanski M, Arion VB, Hartinger CG, Keppler BK (2008) Dalton Trans:183–194
Zhang X-W, Yan X-J, Zhou Z-R, Yang F-F, Wu Z-Y, Sun H-B, Liang W-X, Song A-X, Lallemand-Breitenbach V, Jeanne M, Zhang Q-Y, Yang H-Y, Huang Q-H, Zhou G-B, Tong J-H, Zhang Y, Wu J-H, Hu H-Y, de Thé H, Chen S-J, Chen Z (2010) Science 328:240–243
Dyson PJ, Sava G (2006) Dalton Trans:1929–1933
Sava G, Bergamo A, Dyson PJ (2011) Dalton Trans 40:9069–9075
Sava G, Jaouen G, Hillard EA, Bergamo A (2012) Dalton Trans 41:8226–8234
Graf N, Lippard SJ (2012) Adv Drug Deliv Rev 64:993–1004
Galanski M, Keppler BK (2012) Tumor-targeting strategies with anticancer platinum complexes. In: Kratz F, Senter P, Steinhagen H (eds) Drug delivery in oncology: From basic research to cancer therapy, vol 3, Wiley–VCH Verlag GmbH & Co. KGaA, Weinheim, pp 1605–1629
Gasser G, Ott I, Metzler-Nolte N (2011) J Med Chem 54:3–25
Hartinger CG, Dyson PJ (2009) Chem Soc Rev 38:391–401
Sava G, Zorzet S, Turrin C, Vita F, Soranzo M, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S (2003) Clin Cancer Res 9:1898–1905
Ang WH, Khalaila I, Allardyce CS, Juillerat-Jeanneret L, Dyson PJ (2005) J Am Chem Soc 127:1382–1383
Parker LJ, Italiano LC, Morton CJ, Hancock NC, Ascher DB, Aitken JB, Harris HH, Campomanes P, Rothlisberger U, De Luca A, Lo Bello M, Ang W-H, Dyson PJ, Parker MW (2011) Chem Eur J 17:7806–7816
Blanck S, Maksimoska J, Baumeister J, Harms K, Marmorstein R, Meggers E (2012) Angew Chem Int Ed 51:5244–5246
Meermann B, Sperling M (2012) Anal Bioanal Chem :1–22
Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK (2006) Chem Rev 106:2224–2248
Moller C, Tastesen HS, Gammelgaard B, Lambert IH, Sturup S (2010) Metallomics 2:811–818
Holding JD, Lindup WE, van Laer C, Vreeburg GC, Schilling V, Wilson JA, Stell PM (1992) Br J Clin Pharmacol 33:75–81
Galanski M, Arion VB, Jakupec MA, Keppler BK (2003) Curr Pharm Des 9:2078–2089
Groessl M, Hartinger CG, Polec-Pawlak K, Jarosz M, Keppler BK (2008) Electrophoresis 29:2224–2232
Lippert B (1999) Cisplatin. Chemistry and biochemistry of a leading anticancer drug. VHCA, Zürich
Dickson NR, Jones SF, Burris HA, Ramanathan RK, Weiss GJ, Infante JR, Bendell JC, McCulloch W, Hoff DDV (2011) J Clin Oncol 29:abstr 2607
Shen DW, Pouliot LM, Hall MD, Gottesman MM (2012) Pharmacol Rev 64:706–721
Bergamo A, Sava G (2011) Dalton Trans 40:7817–7823
Mounicou S, Szpunar J, Lobinski R (2009) Chem Soc Rev 38:1119–1138
Templeton DM, Ariese F, Cornelis R, Danielsson LG, Muntau H, van Leeuwen HP, Lobínski R (2000) Pure Appl Chem 72:1453–1470
Shi W, Chance M (2008) Cell Mol Life Sci 65:3040–3048
Esteban-Fernandez D, Moreno-Gordaliza E, Canas B, Palacios MA, Gomez-Gomez MM (2010) Metallomics 2:19–38
Zayed A, Shoeib T, Taylor SE, Jones GDD, Thomas AL, Wood JP, Reid HJ, Sharp BL (2011) Int J Mass Spectrom 307:70–78
Groessl M, Zava O, Dyson PJ (2011) Metallomics 3:591–599
Łobiński R, Schaumlöffel D, Szpunar J (2006) Mass Spectrom Rev 25:255–289
Brouwers EEM, Tibben M, Rosing H, Schellens JHM, Beijnen JH (2008) Mass Spectrom Rev 27:67–100
Clarke MJ (2003) Coord Chem Rev 236:209–233
Polec-Pawlak K, Abramski JK, Semenova O, Hartinger CG, Timerbaev AR, Keppler BK, Jarosz M (2006) Electrophoresis 27:1128–1135
Sulyok M, Hann S, Hartinger CG, Keppler BK, Stingeder G, Koellensperger G (2005) J Anal At Spectrom 20:856–863
Groessl M, Hartinger CG, Egger A, Keppler BK (2006) The binding of ruthenium(III) anticancer complexes to serum proteins: An ESI-MS study. In: Alpoim MC, Morais PV, Santos MA, Cristóvão AJ, Centeno JA, Collery P (eds) Metal ions in biology and medicine, vol 9. Éditions John Libbey Eurotext, Montrouge, pp 111–116
Howell SB, Safaei R, Larson CA, Sailor MJ (2010) Mol Pharmacol 77:887–894
Du X, Wang X, Li H, Sun H (2012) Metallomics
Egger AE, Rappel C, Jakupec MA, Hartinger CG, Heffeter P, Keppler BK (2009) J Anal At Spectrom 24:51–61
Centerwall CR, Tacka KA, Kerwood DJ, Goodisman J, Toms BB, Dubowy RL, Dabrowiak JC (2006) Mol Pharmacol 70:348–355
Sar DG, Montes-Bayón M, Blanco-González E, Sanz-Medel A (2010) Trends Anal Chem 29:1390–1398
Brouwers E, Tibben M, Pluim D, Rosing H, Boot H, Cats A, Schellens J, Beijnen J (2008) Anal Bioanal Chem 391:577–585
Esteban-Fernández D, Verdaguer JM, Ramírez-Camacho R, Palacios MA, Gómez-Gómez MM (2008) J Anal Toxicol 32:140–146
Bytzek AK, Hartinger CG (2012) Electrophoresis 33:622–634
Hartinger CG, Hann S, Koellensperger G, Sulyok M, Groessl M, Timerbaev AR, Rudnev AV, Stingeder G, Keppler BK (2005) Int J Clin Pharmacol Ther 43:583–585
Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H, Keppler BK (2006) J Inorg Biochem 100:891–904
Groessl M, Hartinger CG, Polec-Pawlak K, Jarosz M, Dyson PJ, Keppler BK (2008) Chem Biodivers 5:1609–1614
Groessl M, Bytzek A, Hartinger CG (2009) Electrophoresis 30:2720–2727
Groessl M, Hartinger CG, Dyson PJ, Keppler BK (2008) J Inorg Biochem 102:1060–1065
Bytzek AK, Reithofer MR, Galanski M, Groessl M, Keppler BK, Hartinger CG (2010) Electrophoresis 31:1144–1150
Moller C, Sturup S, Hansen HR, Gammelgaard B (2009) J Anal At Spectrom 24:1208–1212
Timerbaev AR, Aleksenko SS, Polec-Pawlak K, Ruzik R, Semenova O, Hartinger CG, Oszwaldowski S, Galanski M, Jarosz M, Keppler BK (2004) Electrophoresis 25:1988–1995
Szpunar J, Makarov A, Pieper T, Keppler BK, Łobiński R (1999) Anal Chim Acta 387:135–144
Groessl M, Terenghi M, Casini A, Elviri L, Lobinski R, Dyson PJ (2010) J Anal At Spectrom 25:305–313
Allain P, Heudi O, Cailleux A, Le Bouil A, Larra F, Boisdron-Celle M, Gamelin E (2000) Drug Metab Dispos 28:1379–1384
Xie R, Johnson W, Rodriguez L, Gounder M, Hall G, Buckley B (2007) Anal Bioanal Chem 387:2815–2822
Kasherman Y, Sturup S, Gibson D (2009) J Med Chem 52:4319–4328
Perez RP (1998) Eur J Cancer 34:1535–1542
Bytzek AK, Boeck K, Hermann G, Hann S, Keppler BK, Hartinger CG, Koellensperger G (2011) Metallomics 3:1049–1055
Bell DN, Liu JJ, Tingle MD, McKeage MJ (2006) J Chromatogr B 837:29–34
Bosch ME, Sánchez AJR, Rojas FS, Ojeda CB (2008) J Pharm Biomed Anal 47:451–459
Harrington CF, Le Pla RC, Jones GDD, Thomas AL, Farmer PB (2010) Chem Res Toxicol 23:1313–1321
García Sar D, Montes-Bayón M, Blanco González E, Sierra LM, Aguado L, Comendador MA, Koellensperger G, Hann S, Sanz-Medel A (2009) Anal Chem 81:9553–9560
Falta T, Koellensperger G, Standler A, Buchberger W, Mader RM, Hann S (2009) J Anal At Spectrom 24:1336–1342
Konz I, Fernández B, Fernández M, Pereiro R, Sanz-Medel A (2012) Anal Bioanal Chem. doi:10.1007/s00216-00012-06023-00216
Moreno-Gordaliza E, Giesen C, Lazaro A, Esteban-Fernandez D, Humanes B, Canas B, Panne U, Tejedor A, Jakubowski N, Gomez-Gomez MM (2011) Anal Chem 83:7933–7940
Usami N, Furusawa Y, Kobayashi K, Lacombe S, Reynaud-Angelin A, Sage E, Wu T-D, Croisy A, Guerquin-Kern J-L, Le Sech C (2008) Int J Radiat Biol 84:603–611
Wedlock LE, Berners-Price SJ (2011) Aust J Chem 64:692–704
Wedlock LE, Kilburn MR, Cliff JB, Filgueira L, Saunders M, Berners-Price SJ (2011) Metallomics 3:917–925
Yates JR, Ruse CI, Nakorchevsky A (2009) Annu Rev Biomed Eng 11:49–79
Mendes F, Groessl M, Nazarov AA, Tsybin YO, Sava G, Santos I, Dyson PJ, Casini A (2011) J Med Chem 54:2196–2206
Will J, Kyas A, Sheldrick WS, Wolters D (2007) J Biol Inorg Chem 12:883–894
Will J, Sheldrick WS, Wolters D (2008) J Biol Inorg Chem 13:421–434
Hartinger CG, Casini A, Duhot C, Tsybin YO, Messori L, Dyson PJ (2008) J Inorg Biochem 102:2136–2141
Casini A, Karotki A, Gabbiani C, Rugi F, Vasak M, Messori L, Dyson PJ (2009) Metallomics 1:434–441
Cubo L, Groessl M, Casini A, Dyson PJ, Quiroga AG, Navarro-Ranninger C (2010) ChemMedChem 5:1335–1343
Lentz F, Drescher A, Lindauer A, Henke M, Hilger RA, Hartinger CG, Scheulen ME, Dittrich C, Keppler BK, Jaehde U, Re CESAD (2009) Anti-Cancer Drugs 20:97–103
Tran JC, Zamdborg L, Ahlf DR, Lee JE, Catherman AD, Durbin KR, Tipton JD, Vellaichamy A, Kellie JF, Li M, Wu C, Sweet SMM, Early BP, Siuti N, LeDuc RD, Compton PD, Thomas PM, Kelleher NL (2011) Nature 480:254–258
Hartinger CG, Tsybin YO, Fuchser J, Dyson PJ (2008) Inorg Chem 47:17–19
Meier SM, Tsybin YO, Dyson PJ, Keppler BK, Hartinger CG (2012) Anal Bioanal Chem 402:2655–2662
Zhao T, King FL (2011) J Biol Inorg Chem 16:633–639
Zhao T, King FL (2010) J Inorg Biochem 104:186–192
Li H, Lin TY, Van Orden SL, Zhao Y, Barrow MP, Pizarro AM, Qi Y, Sadler PJ, O'Connor PB (2011) Anal Chem 83:9507–9515
Moreno-Gordaliza E, Canas B, Palacios MA, Gomez-Gomez MM (2009) Anal Chem 81:3507–3516
Moreno-Gordaliza E, Canas B, Palacios MA, Gomez-Gomez MM (2010) Analyst 135:1288–1298
Will J, Wolters DA, Sheldrick WS (2008) ChemMedChem 3:1696–1707
Neault JF, Tajmir-Riahi HA (1998) Biochim Biophys Acta 1384:153–159
Allardyce CS, Dyson PJ, Coffey J, Johnson N (2002) Rapid Commun Mass Spectrom 16:933–935
Khalaila I, Allardyce CS, Verma CS, Dyson PJ (2005) ChemBioChem 6:1788–1795
Appleton TG, Connor JW, Hall JR (1988) Inorg Chem 27:130–137
Fröhling CDW, Sheldrick WS (1997) J Chem Soc, Dalton Trans :4411–4420
Hahn M, Kleine M, Sheldrick W (2001) J Biol Inorg Chem 6:556–566
Gstaiger M, Aebersold R (2009) Nat Rev Genet 10:617–627
Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B (2007) Anal Bioanal Chem 389:1017–1031
Simpson RJ, Bernhard OK, Greening DW, Moritz RL (2008) Curr Opin Chem Biol 12:72–77
Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, Hood L, Lin B (2006) Mol Cell Proteomics 5:433–443
Fitzpatrick DP, You JS, Bemis KG, Wery JP, Ludwig JR, Wang M (2007) Proteomics Clin Appl 1:246–263
Guidi F, Landini I, Puglia M, Magherini F, Gabbiani C, Cinellu MA, Nobili S, Fiaschi T, Bini L, Mini E, Messori L, Modesti A (2012) Metallomics 4:307–314
Bindoli A, Rigobello MP, Scutari G, Gabbiani C, Casini A, Messori L (2009) Coord Chem Rev 253:1692–1707
Stefanopoulou M, Kokoschka M, Sheldrick WS, Wolters DA (2011) Proteomics 11:4174–4188
Cho Y-E, Singh TSK, Lee H-C, Moon P-G, Lee J-E, Lee M-H, Choi E-C, Chen Y-J, Kim S-H, Baek M-C (2012) Mol Cell Proteomics 11:
Le Pla RC, Ritchie KJ, Henderson CJ, Wolf CR, Harrington CF, Farmer PB (2007) Chem Res Toxicol 20:1177–1182
Wynne P, Newton C, Ledermann JA, Olaitan A, Mould TA, Hartley JA (2007) Br J Cancer 97:927–933
Egger AE, Hartinger CG, Ben Hamidane H, Tsybin YO, Keppler BK, Dyson PJ (2008) Inorg Chem 47:10626–10633
Groessl M, Tsybin YO, Hartinger CG, Keppler BK, Dyson PJ (2010) J Biol Inorg Chem 15:677–688
Ortega R, Devès G, Carmona A (2009) J R Soc Interface 6:S649–S658
Fahrni CJ (2007) Curr Opin Chem Biol 11:121–127
Levina A, Mitra A, Lay PA (2009) Metallomics 1:458–470
Ilinski P, Lai B, Cai Z, Yun W, Legnini D, Talarico T, Cholewa M, Webster LK, Deacon GB, Rainone S, Phillips DR, Stampfl APJ (2003) Cancer Res 63:1776–1779
Hall M, Dillon C, Zhang M, Beale P, Cai Z, Lai B, Stampfl AJ, Hambley T (2003) J Biol Inorg Chem 8:726–732
Shimura M, Saito A, Matsuyama S, Sakuma T, Terui Y, Ueno K, Yumoto H, Yamauchi K, Yamamura K, Mimura H, Sano Y, Yabashi M, Tamasaku K, Nishio K, Nishino Y, Endo K, Hatake K, Mori Y, Ishizaka Y, Ishikawa T (2005) Cancer Res 65:4998–5002
Crossley EL, Aitken JB, Vogt S, Harris HH, Rendina LM (2010) Angew Chem Int Ed Engl 49:1231–1233
Domaille DW, Que EL, Chang CJ (2008) Nat Chem Biol 4:168–175
Klein AV, Hambley TW (2009) Chem Rev 109:4911–4920
Chen KG, Valencia JC, Lai B, Zhang G, Paterson JK, Rouzaud F, Berens W, Wincovitch SM, Garfield SH, Leapman RD, Hearing VJ, Gottesman MM (2006) Proc Natl Acad Sci 103:9903–9907
Alderden RA, Mellor HR, Modok S, Hambley TW, Callaghan R (2006) Biochem Pharmacol 71:1136–1145
Nazarov AA, Risse J, Ang WH, Schmitt F, Zava O, Ruggi A, Groessl M, Scopelitti R, Juillerat-Jeanneret L, Hartinger CG, Dyson PJ (2012) Inorg Chem 51:3633–3639
Kurzwernhart A, Kandioller W, Bartel C, Bachler S, Trondl R, Muhlgassner G, Jakupec MA, Arion VB, Marko D, Keppler BK, Hartinger CG (2012) Chem Commun 48:4839–4841
Danley DE (2006) Acta Crystallogr D 62:569–575
Cetinbas N, Webb M, Dubland J, Walsby C (2010) J Biol Inorg Chem 15:131–145
Kratz F, Keppler BK, Messori L, Smith C, Baker EN (1994) Met Based Drugs 1:169–173
Smith CA, Sutherland-Smith AJ, Keppler BK, Kratz F, Baker EN (1996) J Biol Inorg Chem 1:424–431
Kratz F, Hartmann M, Keppler B, Messori L (1994) J Biol Chem 269:2581–2588
Messori L, Kratz F, Alessio E (1996) Met Based Drugs 3:1–9
Messori L, Vilchez FG, Vilaplana R, Piccioli F, Alessio E, Keppler B (2000) Met Based Drugs 7:335–342
Pongratz M, Schluga P, Jakupec MA, Arion VB, Hartinger CG, Allmaier G, Keppler BK (2004) J Anal At Spectrom 19:46–51
Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ (1999) Nature 399:708–712
Calderone V, Casini A, Mangani S, Messori L, Orioli PL (2006) Angew Chem Int Ed 45:1267–1269
Weidt SK, Mackay CL, Langridge-Smith PRR, Sadler PJ (2007) Chem Commun: 1719–1721
Wu B, Davey CA (2008) Chem Biol 15:1023–1028
Wu B, Droege P, Davey CA (2008) Nature Chem Biol 4:110–112
Wu B, Davey GE, Nazarov AA, Dyson PJ, Davey CA (2011) Nucleic Acids Res 39:8200–8212
Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, Moore IK, Wang J-PZ, Widom J (2006) Nature 442:772–778
Wu B, Ong MS, Groessl M, Adhireksan Z, Hartinger CG, Dyson PJ, Davey CA (2011) Chemistry Eur J 17:3562–3566
Neidle S (ed) (2008) Cancer: Drug design and discovery. Academic Press, New York
Debreczeni JE, Bullock AN, Atilla GE, Williams DS, Bregman H, Knapp S, Meggers E (2006) Angew Chem Int Ed 45:1580–1585
Pagano N, Maksimoska J, Bregman H, Williams DS, Webster RD, Xue F, Meggers E (2007) Org Biomol Chem 5:1218–1227
Atilla-Gokcumen GE, Pagano N, Streu C, Maksimoska J, Filippakopoulos P, Knapp S, Meggers E (2008) ChemBioChem 9:2933–2936
Xie P, Williams DS, Atilla-Gokcumen GE, Milk L, Xiao M, Smalley KSM, Herlyn M, Meggers E, Marmorstein R (2008) ACS Chem Biol 3:305–316
Maksimoska J, Feng L, Harms K, Yi C, Kissil J, Marmorstein R, Meggers E (2008) J Am Chem Soc 130:15764–15765
Bullock AN, Russo S, Amos A, Pagano N, Bregman H, Debreczeni JE, Lee WH, von Delft E, Meggers E, Knapp S (2009) PLoS One 4:e7112 7111–7117
Xie P, Streu C, Qin J, Bregman H, Pagano N, Meggers E, Marmorstein R (2009) Biochemistry 48:5187–5198
Feng L, Geisselbrecht Y, Blanck S, Wilbuer A, Atilla-Gokcumen GE, Filippakopoulos P, Kraling K, Celik MA, Harms K, Maksimoska J, Marmorstein R, Frenking G, Knapp S, Essen L-O, Meggers E (2011) J Am Chem Soc 133:5976–5986
Atilla-Gokcumen GE, Di CL, Meggers E (2011) J Biol Inorg Chem 16:45–50
Meggers E (2009) Chem Commun: 1001–1010
Papayannopoulos IA (1995) Mass Spectrom Rev 14:49–73
Jolly Graham A, Potti A (2009) Current Oncol Rep 11:263–268
Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, Villegas E, Jacquemont C, Farrugia DJ, Couch FJ, Urban N, Taniguchi T (2008) Nature 451:1116–1120
Khrunin AV, Moisseev A, Gorbunova V, Limborska S (2009) Pharmacogenomics J 10:54–61
Joerger M, Burgers J, Baas P, Doodeman V, Smits P, Jansen R, Vainchtein L, Rosing H, Huitema A, Beijnen J, Schellens J (2012) Cancer Chemother Pharmacol 69:25–33
Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, Gray J, Marks J, Ginsburg GS, Potti A, West M, Nevins JR, Lancaster JM (2007) J Clin Oncol 25:517–525
Riedel RF, Porrello A, Pontzer E, Chenette EJ, Hsu DS, Balakumaran B, Potti A, Nevins J, Febbo PG (2008) Mol Cancer Ther 7:3141–3149
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A, Green JE (2011) PLoS One 6:e16694
Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis GR, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS (2007) Nature 447:655–660
Collins F (2010) Nature 464:674–675
Marshall E (2011) Science 331:526–529
Acknowledgments
CGH is grateful for financial support from the University of Auckland, the Austrian Science Fund and the Johanna Mahlke geb. Obermann Foundation. The authors acknowledge financial support from the University of Vienna, the Austrian Science Fund (FWF), and the COST actions D39, CM1105 and CM0902.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection Metallomics with guest editors Uwe Karst and Michael Sperling.
Rights and permissions
About this article
Cite this article
Groessl, M., Hartinger, C.G. Anticancer metallodrug research analytically painting the “omics” picture—current developments and future trends. Anal Bioanal Chem 405, 1791–1808 (2013). https://doi.org/10.1007/s00216-012-6450-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-012-6450-4